This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erler, J. T. Articles by Dive, C. Search for Related Content PubMed PubMed Citation Articles by Erler, J. T. Articles by Dive, C.

Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance

Cellular and Molecular Pharmacology Group,¹ Bioinformatics Group, Paterson Institute for Cancer Research, Manchester M20 4BX,⁴ School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester M13 9PT, United Kingdom,² Grow Research Institute, University of Maastricht, Maastricht, The Netherlands³

Received 29 July 2003/ Returned for modification 12 September 2003/ Accepted 5 January 2004

Solid tumors with disorganized, insufficient blood supply contain hypoxic cells that are resistant to radiotherapy and chemotherapy. Drug resistance, an obstacle to curative treatment of solid tumors, can occur via suppression of apoptosis, a process controlled by pro- and antiapoptotic members of the Bcl-2 protein family. Oxygen deprivation of human colon cancer cells in vitro provoked decreased mRNA and protein levels of proapoptotic Bid and Bad. Hypoxia-inducible factor 1 (HIF-1) was dispensable for the down-regulation of Bad but required for that of Bid, consistent with the binding of HIF-1 to a hypoxia-responsive element (positions -8484 to -8475) in the bid promoter. Oxygen deprivation resulted in proteosome-independent decreased expression of Bax in vitro, consistent with a reduction in global translation efficiency. The physiological relevance of Bid and Bax down-regulation was confirmed in tumors in vivo. Oxygen deprivation resulted in decreased drug-induced apoptosis and clonogenic resistance to agents with different mechanisms of action. The contribution of Bid and/or Bax down-regulation to drug responsiveness was demonstrated by the relative resistance of normoxic cells that had no or reduced expression of Bid and/or Bax and by the finding that forced expression of Bid in hypoxic cells resulted in increased sensitivity to the topoisomerase II inhibitor etoposide.

This article has been cited by other articles:

• Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., Maclennan, S., Baraldi, P. G., Borea, P. A. (2007). Hypoxia Inhibits Paclitaxel-Induced Apoptosis through Adenosine-Mediated Phosphorylation of Bad in Glioblastoma Cells. Mol. Pharmacol. 72: 162-172 [Abstract] [Full Text]  
• Rezvani, H. R., Dedieu, S., North, S., Belloc, F., Rossignol, R., Letellier, T., de Verneuil, H., Taieb, A., Mazurier, F. (2007). Hypoxia-inducible Factor-1{alpha}, a Key Factor in the Keratinocyte Response to UVB Exposure. J. Biol. Chem. 282: 16413-16422 [Abstract] [Full Text]  
• Wouters, A., Pauwels, B., Lardon, F., Vermorken, J. B. (2007). Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions. The Oncologist 12: 690-712 [Abstract] [Full Text]  
• WINCEWICZ, A., SULKOWSKA, M., KODA, M., KANCZUGA-KODA, L., WITKOWSKA, E., SULKOWSKI, S. (2007). Significant Coexpression of GLUT-1, Bcl-xL, and Bax in Colorectal Cancer. Ann. N. Y. Acad. Sci. 1095: 53-61 [Abstract] [Full Text]  
• Kroemer, G., Galluzzi, L., Brenner, C. (2007). Mitochondrial Membrane Permeabilization in Cell Death. Physiol. Rev. 87: 99-163 [Abstract] [Full Text]  
• Kimbro, K S, Simons, J W (2006). Hypoxia-inducible factor-1 in human breast and prostate cancer.. Endocr Relat Cancer 13: 739-749 [Abstract] [Full Text]  
• Hussein, D., Estlin, E. J., Dive, C., Makin, G. W.J. (2006). Chronic hypoxia promotes hypoxia-inducible factor-1{alpha}-dependent resistance to etoposide and vincristine in neuroblastoma cells.. Molecular Cancer Therapeutics 5: 2241-2250 [Abstract] [Full Text]  
• Generali, D., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Wigfield, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., Gandolfi, V., Dogliotti, L., Bottini, A., Harris, A. L., Fox, S. B. (2006). Hypoxia-Inducible Factor-1{alpha} Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer. Clin. Cancer Res. 12: 4562-4568 [Abstract] [Full Text]  
• Brown, L. M., Cowen, R. L., Debray, C., Eustace, A., Erler, J. T., Sheppard, F. C. D., Parker, C. A., Stratford, I. J., Williams, K. J. (2006). Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1. Mol. Pharmacol. 69: 411-418 [Abstract] [Full Text]  
• Das, B., Yeger, H., Tsuchida, R., Torkin, R., Gee, M. F.W., Thorner, P. S., Shibuya, M., Malkin, D., Baruchel, S. (2005). A Hypoxia-Driven Vascular Endothelial Growth Factor/Flt1 Autocrine Loop Interacts with Hypoxia-Inducible Factor-1{alpha} through Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase 1/2 Pathway in Neuroblastoma. Cancer Res. 65: 7267-7275 [Abstract] [Full Text]  
• Karlsson, J., Edsjo, A., Pahlman, S., Pettersson, H. M. (2005). Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia. Molecular Cancer Therapeutics 4: 1128-1135 [Abstract] [Full Text]  
• Papandreou, I., Krishna, C., Kaper, F., Cai, D., Giaccia, A. J., Denko, N. C. (2005). Anoxia Is Necessary for Tumor Cell Toxicity Caused by a Low-Oxygen Environment. Cancer Res. 65: 3171-3178 [Abstract] [Full Text]  
• Xie, L., Johnson, R. S., Freeman, R. S. (2005). Inhibition of NGF deprivation-induced death by low oxygen involves suppression of BIMEL and activation of HIF-1. J. Cell Biol. 168: 911-920 [Abstract] [Full Text]  
• Piret, J.-P., Minet, E., Cosse, J.-P., Ninane, N., Debacq, C., Raes, M., Michiels, C. (2005). Hypoxia-inducible Factor-1-dependent Overexpression of Myeloid Cell Factor-1 Protects Hypoxic Cells against tert-Butyl Hydroperoxide-induced Apoptosis. J. Biol. Chem. 280: 9336-9344 [Abstract] [Full Text]  
• Xu, R.-h., Pelicano, H., Zhou, Y., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., Huang, P. (2005). Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia. Cancer Res. 65: 613-621 [Abstract] [Full Text]  
• Ricker, J. L., Chen, Z., Yang, X. P., Pribluda, V. S., Swartz, G. M., Van Waes, C. (2004). 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor 1{alpha}, Tumor Growth, and Angiogenesis and Augments Paclitaxel Efficacy in Head and Neck Squamous Cell Carcinoma. Clin. Cancer Res. 10: 8665-8673 [Abstract] [Full Text]